Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy

Aras, Cengiz; Senturk, Fevzi; Erdur, Sevil Karaman; Kocabora, Mehmet Selim; Dogramaci, Mahmut; Burke, Cahit; Aras, Efe

doi:10.5935/0004-2749.2023-0001

Contact

Submission

Youtube

Open Access

Peer-Reviewed
Artigo Original

Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy

Cengiz Aras¹; Fevzi Senturk¹; Sevil Karaman Erdur¹; Mehmet Selim Kocabora¹; Mahmut Dogramaci²; Cahit Burke¹; Efe Aras³

DOI: 10.5935/0004-2749.2023-0001

1. Department of Ophthalmology, Medicine Faculty, Istanbul Medipol University, Istanbul, Turkey
2. Department of Ophthalmology, The Princess Alexandra Hospital NHS Trust, London, UK
3. Medicine Faculty, Yeditepe University, Istanbul, Turkey

Corresponding author

Cengiz Aras
E-mail: [email protected]

English PDF
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter
Share on Linkedin
Share on WhatsApp
Share on WhatsApp

Dimension

Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy

Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy

Arquivos Brasileiros de Oftalmologia